FDA Asked to Approve Darzalex Triple Combo for Relapsed or Refractory Multiple Myeloma
Janssen has asked the U.S. Food and Drug Administration (FDA) to allow Darzalex…
News
Antibiotics Prevent Fevers, Death in Newly Diagnosed Myeloma Patients, Study Says
Preventive treatment with the antibiotic levofloxacin can lower the incidence of fever and death in people newly diagnosed with multiple myeloma, results from a…
Advancing Novel Cell Therapy for Myeloma and Multiple Cancers Goal of New Partnership
A recent partnership between Indapta Therapeutics and Lonza is advancing the development of an off-the-shelf cell therapy designed to treat multiple types of cancers, including…
EMA Reviewing Belantamab Mafodotin for Heavily Pretreated Multiple Myeloma
The European Medicines Agency has agreed to review the application of  GlaxoSmithKline‘s belantamab mafodotin for the treatment of heavily treated multiple myeloma patients, the company…
Takeda, Snow Myeloma App ‘Being Patient’ Wins Pharma Choice Award
Takeda and Snow Companies won one of the top prizes in PM360’s annual Pharma Choice Awards for an app aimed at…
Researchers Provide Highlights on Study into Benefits of Reolysin, Kyprolis Combo in Multiple Myeloma
Researchers are continuing to study how the combination of Oncolytics Biotech‘s virus-based anti-cancer therapy Reolysin (pelareorep) and Kyprolis (carfilzomib) provides benefits…
Allogene, SpringWorks Collaborate to Test ALLO-715, Nirogacestat Combo for RRMM
Allogene Therapeutics and SpringWorks Therapeutics have launched a clinical trial collaboration to conduct a Phase…
Sanofi Partners to Develop Diagnostic Test for Multiple Myeloma Patients on Potential Therapy
Sanofi announced that it partnered with Sebia to develop a new multiple myeloma diagnostic test that will help to mitigate the interference of isatuximab…
FDA Grants Priority Review to Belantamab Mafodotin for Heavily-treated Multiple Myeloma
The U.S. Food and Drug Administration (FDA) has granted priority review status to GlaxoSmithKline‘s application seeking the approval of belantamab mafodotin for the treatment of heavily…
Darzalex Combo Approved in Europe to Treat Transplant-eligible Myeloma Patients
The European Commission has approved Darzalex (daratumumab), in combination with standard pre-transplant therapy, to treat newly diagnosed multiple myeloma patients who are…
Recent Posts
- Treatment before surgery slows PDAC disease progression: Study
- Scientists discover tissue differences in brain cancer in children
- Elahere approved in EU as treatment for ovarian cancer
- Survival better with Blenrep combo than Darzalex for R/R myeloma
- Aucatzyl, a cell therapy, approved in US for adults with advanced B-ALL